Update on novel therapeutic agents for cervical cancer .A prospective phase Ⅰ‐Ⅱ trial of the cyclooxygenase‐2inhibitorcelecoxibin patients with carcinoma of the cervix with biomarker assessment of thetumor microenvi ronment .A phase Ⅱ study of sunitinib i ......